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Giuseppe BorzacchielloAbstract
Bovine papillomaviruses (BPVs) induce hyperplastic and tumoral lesions not only in cows but also in other different
animal species. The transforming activity of BPVs is due to its major E5 oncogene. Recent studies have highlighted
the role of E5 in cancer development but very little is known about E6 and E7 oncogenes. In this letter we argue
for the need of investigating E6 as well as E7 to better understand the role of these two oncogenes during
carcinogenesis.
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Bovine papillomavirus (BPV) is considered as causative
agent of cutaneous and mucosal tumors in its natural
host [1]. However, BPV is the only papillomavirus (PV)
able to cross infect other species being associated to
tumors also in equids [2] buffaloes [3,4], yaks [5],
giraffes [6], tapirs [7], zebras and bison [6,8]. BPV has
been also largely investigated as animal model to better
understand the transforming activity of Pvs. BPV
attracted the interest of molecular biologists since it
was the first Pv able to induce transformation in
cultured non-epithelial cells; furthermore its genome
was the first among PVs to be completely sequenced
[9]. Further genetic analysis identified two BPV early
(E) genes, E5 and E6, with a direct role in cell trans-
formation [10,11]. E5 was identified as the major BPV
oncogene whose transformation activity lies in its
binding to and activation of the β subunit of the plate-
let derived growth factor receptor (PDGFβ-r) [12].
Most if not all these observations were derived from
in vitro studies.
In the last decade, the role of BPV major oncoprotein
E5 in cell transformation has been largely investigated
in naturally occurring bovine and equine tumors.
Overall, these studies confirmed the pivotal role of E5
in cancer development supporting the role of the virus
[13-18]. Interestingly, new facets of BPV infection andCorrespondence: borzacch@unina.it
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reproduction in any medium, provided the orpathogenesis have come to light from recent in vivo
studies paving the way for new fields of speculation
about PV biology, thus confirming the importance of
BPV as animal model [19].
Pv’s contribution to tumorigenesis is “paradigmatic-
ally” based on the actions of more than one onco-
gene. Human Pvs (HPVs) E5, E6 and E7 oncoproteins
act synergistically disturbing different cellular path-
ways and in so doing they contribute to initiation and
progression of cancer [20]. Moreover, only the activity
of both HPV E6 and E7 immortalize primary culture
cells [21].
In this regard, among BPV’s oncogenes the contribu-
tion of the other two oncogenes (E6 and E7) to cancer
development is less known. It has been suggested that
BPV E7 may cooperate with E5 in inducing cell trans-
formation whereas E6 can downregulate p53 transcrip-
tional activity by interacting with CBP/300 [22-24].
However, the contribution of BPV to cancer develop-
ment, according to “PV’s paradigm”, may not result
only from E5 oncoprotein’s activity [25]. More and
more studies should investigate BPV E6 and E7 to
understand their possible role in animal cancer devel-
opment in order to better define the molecular sce-
nario of bovine and equids tumors. Moreover, from a
comparative point of view, further investigations on
BPVs will still give a contribute to discovering new
aspects of PV’s biology and pathology.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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